Dimensional Fund Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Dimensional Fund Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,625	Closed	-$23.9K	–	3524
2023 Q1	$23.9K	Buy	+2,625	New	+$37.2K	﹤0.01%	3430
2022 Q3	$56K	Sell	2,625 -169	-6%	-$4.56K	﹤0.01%	3394
2022 Q2	$68K	Sell	2,794 -679	-20%	-$23.1K	﹤0.01%	3371
2022 Q1	$173K	Sell	3,473 -2,372	-41%	-$117K	﹤0.01%	3330
2021 Q4	$410K	Buy	5,845 +5,371	+1,133%	+$453K	﹤0.01%	3214
2021 Q3	$44K	Buy	474 +21	+5%	+$2K	﹤0.01%	3480
2021 Q2	$45K	Buy	+453	New	+$44.2K	﹤0.01%	3442
2020 Q2	–	Sell	-2,426	Closed	-$69K	–	3365
2020 Q1	$69K	Hold	2,426	–	–	﹤0.01%	3299
2019 Q4	$100K	Sell	2,426 -123	-5%	-$2.69K	﹤0.01%	3318
2019 Q3	$36K	Hold	2,549	–	–	﹤0.01%	3398
2019 Q2	$89K	Hold	2,549	–	–	﹤0.01%	3402
2019 Q1	$143K	Hold	2,549	–	–	﹤0.01%	3351
2018 Q4	$122K	Sell	2,549 -150	-6%	-$8.23K	﹤0.01%	3343
2018 Q3	$196K	Hold	2,699	–	–	﹤0.01%	3316
2018 Q2	$223K	Buy	+2,699	New	+$261K	﹤0.01%	3233

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors's VBIV Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 2,625 shares — an estimated $23.9K sold.

Dimensional Fund Advisors first reported a position in VBIV in Q2 2018 and held it in 15 quarters. The position peaked at $410K in Q4 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

Dimensional Fund Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
Dimensional Fund Advisors sold 2,625 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $23.9K.
Dimensional Fund Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2018 and held it in 15 quarters.
Dimensional Fund Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $410K in Q4 2021.
46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.